SSc | Systemic sclerosis |
ILD | Interstitial lung disease |
HRCT | High-resolution computed tomography |
PFTs | Pulmonary function tests |
DLCO | Diffusion of the lung for carbon oxide |
FVC | Forced vital capacity |
EUSTAR | European Scleroderma Trial and Research |
dcSSc | Diffuse cutaneous subset of SSc |
lcSSc | Limited cutaneous subset of SSc |
ACA | Anticentromere antibodies |
Topo-I | Anti-topoisomerase I |
RNA-Pol III | Anti-RNA polymerase III antibodies |